Exome sequencing in amyotrophic lateral sclerosis identifies risk genes and pathways

ET Cirulli, BN Lasseigne, S Petrovski, PC Sapp… - Science, 2015 - science.org
Science, 2015science.org
Amyotrophic lateral sclerosis (ALS) is a devastating neurological disease with no effective
treatment. We report the results of a moderate-scale sequencing study aimed at increasing
the number of genes known to contribute to predisposition for ALS. We performed whole-
exome sequencing of 2869 ALS patients and 6405 controls. Several known ALS genes
were found to be associated, and TBK1 (the gene encoding TANK-binding kinase 1) was
identified as an ALS gene. TBK1 is known to bind to and phosphorylate a number of proteins …
Amyotrophic lateral sclerosis (ALS) is a devastating neurological disease with no effective treatment. We report the results of a moderate-scale sequencing study aimed at increasing the number of genes known to contribute to predisposition for ALS. We performed whole-exome sequencing of 2869 ALS patients and 6405 controls. Several known ALS genes were found to be associated, and TBK1 (the gene encoding TANK-binding kinase 1) was identified as an ALS gene. TBK1 is known to bind to and phosphorylate a number of proteins involved in innate immunity and autophagy, including optineurin (OPTN) and p62 (SQSTM1/sequestosome), both of which have also been implicated in ALS. These observations reveal a key role of the autophagic pathway in ALS and suggest specific targets for therapeutic intervention.
AAAS